Table 2. Median disaggregated costs incurred by 40 patients (households) from the stage of presumptive MDR TB to pre-MDR TB treatment evaluation, India, August 2016–April 2017* .

Cost category	Median (IQR), USD
Total income	608.00 (228.00–912.00)
Total direct medical costs†	37.44 (7.10–198.24)
Total diagnosis, n = 38	01.58 (0.30–2.40)
Total investigation, n = 36	17.70 (3.19–60.27)
Total treatment, n = 26	15.07 (11.30–47.08)
Total admission, n = 15	45.20 (30.13–75.34)
Total direct nonmedical costs‡	51.20 (28.00–85.36)
Total food, n = 38	35.41 (18.08–64.97)
Total travel, n = 39	12.84 (5.73–12.84)
Total accommodations, n = 1	36.16 (36.16–36.16)
Additional nutrition, n = 38	01.51 (0.75–3.77)
Total direct costs§	105.12 (48.75–306)
Total indirect costs, n = 18¶	51.20 (1.60–306.00)
Total expenditures#	171.31 (72.00–432.00)
Total coping costs	640.00 (324.00–1,360)

*Because all patients did not incur all categories of costs, n differs for different categories. Median (IQR) is calculated only for those who incurred a given cost. IQR, interquartile range; MDR TB, multidrug-resistant TB; TB, tuberculosis: USD, US dollars.
†Direct medical costs = sum of diagnosis investigation (general investigation and disease-specific investigations), complete blood count, erythrocyte sedimentation rate, liver function testing, renal function testing, spirometry, computed tomography, magnetic resonance imaging. Disease specific cost = sputum-smear microscopy, culture, drug-susceptibility testing, radiography, drugs, and hospitalization.
‡Direct nonmedical costs = sum of food, accommodation, travel by both patient and attendant.
§Direct costs = sum of total direct medical costs and total direct nonmedical costs.
¶Indirect costs = loss of wages for patient and attendant during the visit. 
#Total expenditure = sum of total direct and total indirect costs.